Basic Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Jun 28, 2024; 30(24): 3086-3105
Published online Jun 28, 2024. doi: 10.3748/wjg.v30.i24.3086
Table 1 Composition of Qingre Huashi decoction
Authorities name
Scientific name
Plant part
Weight ratio (g)
HuanglianCoptis chinensis Franch.Rhizome6
ZhiziGardenia jasminoides EllisFruit6
PugongyingTaraxacum mongolicum Hand-Mazz.Whole plant15
KuxingrenPrunus armeniaca L. var. ansu Maxim.Seed10
DoukourenAmomun kravanh Pierre ex Gagnep.Fruit6
YiyirenCoix lacryma-jobi L. var. ma-yuen (Roman.) StapfSeed15
BanxiaPinellia ternata (Thunb) Breit.Tuber10
CangzhuAtractylodes lancea (Thunb.) DC.Rhizome10
HoupoMagnolia Officinalis Rehd Et Wils.Bark10
FulingPoria Cocos (Schw.) Wolf.Sclerotium15
CheqiancaoPlantago asiatica L.Whole plant15
Table 2 Information of 12 Helicobacter pylori-infected individuals
No.
Gender
Age
Gastroscopic diagnosis
Pathological diagnosis
13C
1M47Superficial gastritis; duodenal bulb inflammation (mild)Mild chronic gastritis in the gastric body, activity grade II, lymphoid follicle formation, and mucosal erosion32.4
2F39Superficial gastritisModerate chronic gastritis in the gastric antrum, activity grade II, and mucosal erosion26.7
3F54Chronic atrophic gastritisMild chronic gastritis in the gastric antrum, activity grade I, mild intestinal metaplasia. Mild chronic gastritis in the gastric fundus, and severe intestinal metaplasia19.8
4M64Reflux esophagitis (LA-A); superficial gastritis; duodenal bulb ulcer (H1 stage)Moderate chronic gastritis in the gastric antrum, activity grade II, mucosal hyperplasia, lymphoid follicle formation, and fundic gland polyp in the gastric fundus40.5
5F35Chronic non-atrophic gastritis; bile refluxMild chronic inflammation in the gastric body, and activity grade II. Moderate chronic gastritis in the gastric antrum, activity grade II, and lymphoid follicle formation42.2
6F42Chronic non-atrophic gastritis; Helicobacter pylori infectionModerate chronic inflammation in the gastric antrum, and activity grade II27.5
7M32Reflux esophagitis (LA-B); hiatal hernia; chronic atrophic gastritis C2Moderate chronic gastritis in the gastric antrum, activity grade II28.9
8M34Chronic atrophic gastritis with intestinal metaplasia and gastric ulcerModerate chronic gastritis in the gastric antrum, activity grade II, mild intestinal metaplasia, mild atrophy, mucosal hyperplasia, lymphoid follicle formation. Mild chronic inflammation in the cardia, and activity grade I24.3
9F35Chronic superficial gastritis; bile reflux; duodenal bulb ulcerSevere chronic inflammation in the gastric antrum, activity grade II, and lymphoid follicle formation25.4
10F40Hiatal hernia; chronic gastritis with intestinal metaplasiaModerate chronic gastritis in the gastric antrum (site 1), activity grade II, mild intestinal metaplasia, and moderate glandular atrophy17.3
11F46Duodenal ulcer; chronic gastritis; bile refluxNA18.3
12M42Superficial gastritisMild chronic gastritis in the gastric antrum, and focal lymphocyte aggregation16.4
Table 3 Interpretation of biofilm production
Average optical density value
Biofilm production
≤ ODcNo
ODc < OD ≤ 2 × ODcWeak
2 × ODc < OD ≤ 4 × ODcModerate
> 4 × ODcStrong
Table 4 Primer sequences for quantitative polymerase chain reaction
Primer name
Sequence (5’→3’)
Primer name
Sequence (5’→3’)
16S rRNA-FGCTAAGAGATCAGCCTATGTCCSpot-FTGTGCAACCTGTCGCTAATC
16S rRNA-RTGGCAATCAGCGTCAGGTAATGSpot-RTTGGGCAAGATGTGGCTAAT
HP0605-FAGCGCAAGAACTCAGTGTCALUXS-FTGGATCACACYAAAGTCAAAG
HP0605-RGCTTGGAGTTGTTGGGTGTTLUXS-RAAACCCCCACTTCAGACCA
HP1327-FGCCAGGCTTGATGAAGAAAAcagE-FTTGAAAACTTCAAGGATAGGATAGAGC
HP1327-RTTAGCCTGCTTGCCGTAAATcagE-RGCCTAGCGTAATATCACCATTACCC
HP1489-FTAGGCGCTCAAGTGGCTTATgluP-FCCGCTGGTAATCCCTTTGTA
HP1489-RTCAGATCGGGCAGATTTTTCgluP-RCTTGCATTATCGCCCATTTT
HP0971-FTTACCGGCAAAGGGATACGnapA-FTGAAGAGTTTGCGGACAT
HP0971-RAAATTGGATCGCTCGTTGTATGnapA-RAGAGTGGAAGCTCGTTTT
Table 5 Primers sequences for polymerase chain reaction-agarose gel electrophoresis
Primer name
Sequence (5’→3’)
Primer name
Sequence (5’→3’)
16S rRNA-FGCTAAGAGATCAGCCTATGTCCvacA m1/m2-FCAATCTGTCCAATCAAGCGAG
16S rRNA-RTGGCAATCAGCGTCAGGTAATGvacA m1/m2-RGCGTCAAAATAATTCCAAGG
CagA-FGTTGATAACGCTGTCGCTTCUreB-FAGTAGCCCGGTGAACACAACATCCT
CagA-RGGGTTGTATGATATTTTCCATAAUreB-RATGCCTTTGTCATAAGCCGCTTGG
vacA s1/s2-FATGGAAATACAACAAACACACUreA-FTGATGGGACCAACTCGTAACCGT
vacA s1/s2-RCTGCTTGAATGCGCCAAACUreA-RCGCAATGTCTAAGCGTTTGCCGAA
Table 6 Typing of Helicobacter pylori strains
No.
CagA
VacA
UreA
UreB
Helicobacter pylori strain type
1+++-I
2++++I
3++++I
4++++I
5+++-I
6-+++I
7++++I
8-+++I
9++++I
10++++I
11++++I
12-+++I
Table 7 Minimum inhibitory concentration of antibiotics against 12 clinical strains of Helicobacter pylori
Helicobacter pylori strain
AML (μg/mL)
CLR (μg/mL)
LEV (μg/mL)
MTZ (μg/mL)
10.01616.000132.000164.001
20.06424.000132.0001256.001
30.0168.000132.0001256.001
40.06416.000132.0001256.001
50.06432.00010.125256.001
60.0168.00013.00011.00
70.06416.000132.00010.38
80.0160.0160.25032.001
90.0160.0640.094256.001
100.0160.0161.5000.50
110.0160.0160.0321.00
120.0160.0160.0321.50
Table 8 Minimum inhibitory concentration of Qingre Huashi decoction against Helicobacter pylori
Helicobacter pylori strain
Concentration of QHD (mg/mL)
NC (0)
16
32
64
128
256
1+++---
2+++---
3+++---
4+++---
5+++---
6+++---
7+++---
8++----
9+++---
10+++---
11+++---
12+++---